Sanara MedTech Inc.

NasdaqCM:SMTI Stock Report

Market Cap: US$285.3m

Sanara MedTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SMTI?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,429,50716.4%
General Public2,115,91224.2%
Private Companies2,547,93429.1%
Individual Insiders2,647,80830.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.2%
Catalyst Rochal, Llc
2,547,934US$83.2m0%no data
11.7%
Ronald Nixon
1,020,364US$33.3m0%no data
11.1%
James Stuckert
966,972US$31.6m0%no data
5.87%
Tall Pines Capital, LLC
512,872US$16.7m0%no data
5.61%
S. Howell
490,394US$16.0m0%no data
2.37%
BlackRock, Inc.
206,862US$6.8m5%no data
1.98%
The Vanguard Group, Inc.
173,012US$5.6m18.9%no data
1.14%
Stonebridge Wealth Management, LLC
100,065US$3.3m0%no data
1.01%
Geode Capital Management, LLC
88,271US$2.9m4.44%no data
0.67%
State Street Global Advisors, Inc.
58,688US$1.9m9.17%no data
0.56%
Zachary Fleming
48,854US$1.6m0%no data
0.46%
Northern Trust Global Investments
40,458US$1.3m31.9%no data
0.3%
Janney Montgomery Scott LLC, Asset Management Arm
26,315US$858.9k-19.9%no data
0.3%
Michael McNeil
25,998US$848.6k0%no data
0.24%
World Investment Advisors, LLC
21,112US$689.1k-18.5%0.02%
0.23%
Citadel Advisors LLC
20,493US$668.9k0%no data
0.23%
Ann Salamone
19,895US$649.4k0%no data
0.22%
Bob DeSutter
19,455US$635.0k0%no data
0.22%
Royal Bank of Canada, Banking & Securities Investments
19,398US$633.2k58.1%no data
0.2%
Sara Ortwein
17,522US$571.9k0%no data
0.16%
Eric Tanzberger
14,068US$459.2k0%no data
0.16%
Renaissance Technologies LLC
14,000US$457.0k-0.71%no data
0.15%
Squarepoint OPS LLC
13,528US$441.5k0%no data
0.15%
Roszell Mack
13,101US$427.6k0%no data
0.15%
Morgan Stanley, Investment Banking and Brokerage Investments
12,836US$419.0k79.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 12:24
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sanara MedTech Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ross OsbornCantor Fitzgerald & Co.
Yi ChenH.C. Wainwright & Co.